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Abstract
Background:  A common SNP upstream of the INSIG2 gene, rs7566605 (g.-10,1025G>C,
Chr2:118,552,255, NT_022135.15), was reported to be associated with obesity (Body Mass Index,
[BMI]) in a genome-wide association scan using the Framingham Heart Study but has not been
reproduced in other cohorts. As BMI is a relatively insensitive measure of adiposity that is subject
to many confounding variables, we sought to determine the relationship between the INSIG2 SNP
and subcutaneous fat volumes measured by MRI in a young adult population.
Methods: We genotyped the INSIG2 SNP rs7566605 in college-aged population enrolled in a
controlled resistance-training program, (the Functional Polymorphism Associated with Human
Muscle Size and Strength, FAMuSS cohort, n = 752 volunteers 18–40 yrs). In this longitudinal study,
we examined the effect of the INSIG2 polymorphism on subcutaneous fat and muscle volumes of
the upper arm measured by magnetic resonance imaging (MRI) before and after 12 wks of
resistance training. Gene/phenotype associations were tested using an analysis of covariance model
with age and weight as covariates. Further, the % variation in each phenotype attributable to
genotype was determined using hierarchical models and tested with a likelihood ratio test.
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Results: Women with a copy of the C allele had higher levels of baseline subcutaneous fat (GG: n
= 139; 243473 ± 5713 mm3 vs. GC/CC: n = 181; 268521 ± 5003 mm3; p = 0.0011); but men did
not show any such association. Men homozygous for the G ancestral allele showed a loss of
subcutaneous fat, while those with one or two copies of the C allele gained a greater percentage
of subcutaneous fat with resistance training (GG: n = 103; 1.02% ± 1.74% vs. GC/CC: n = 93; 6.39%
± 1.82%; p = 0.035).
Conclusion: Our results show that the INSIG2 rs7566605 polymorphism underlies variation in
subcutaneous adiposity in young adult women and suppresses the positive effects of resistance
training on men. This supports and extends the original finding that there is an association between
measures of obesity and INSIG2  rs7566605 and further implicates this polymorphism in fat
regulation.
Background
Obesity is increasing in prevalence and is an important
public health problem. In the United States, 17.1% of
children 2 to 19 years are overweight and 32.2% of adults
aged > 20 years are obese. The prevalence of being over-
weight among children and adolescents and obesity
among men increased significantly between 1999 and
2004 [1]. Obesity is a major risk factor for the develop-
ment of hypertension, diabetes, coronary heart disease,
and stroke [1]. Genetic predisposition is known to under-
lie much of the obese and morbid obesity phenotype,
with approximately 50% of effect environmental (diet,
exercise) and between 30–70% genetically determined
[2]. Phenotypic measures of obesity vary considerably
between different studies, and this can complicate the
interpretation of genetic association studies. Body mass
index (BMI) is a frequently used measure of obesity, yet it
considers only weight as a function of height, and does
not measure fat distribution (visceral vs. subcutaneous) or
relative contribution of muscle and fat to the BMI. As a
result, professional body builders are often classified as
obese or morbidly obese by measures of BMI [2,3].
Herbert et al. [4] conducted a genome-wide association
study to identify genetic loci (single nucleotide polymor-
phisms; SNPs) contributing to obesity using BMI as the
primary phenotype. The authors reported strong statistical
evidence that the INSIG2 promoter SNP rs7566605 (g.-
10,1025G>C, Chr2:118,552,255, NT_022135.15) was
associated with increased BMI in a cohort of the 694 par-
ticipants in the Framingham Heart Study [4]. In this initial
report, association of rs7566605 with BMI was replicated
in ethnically distinct populations, including European
and African Americans. INSIG2 is a ~21.5 Kb gene located
on chromosome 2q14 that has been functionally linked
to lipid metabolism, most notably due to its role in
endogenous cholesterol and fatty acid synthesis feedback
inhibition [5]. It is an endoplasmic reticulum membrane
bound protein that inhibits the proteolytic activation of
Sterol Response Element Binding Proteins (SREPs) in
response to cholesterol or insulin [5]. Animal data suggest
a role for INSIG2 in regulating triglyceride levels in rats
[6].
Data mapping of quantitative trait loci in mice (QTL) for
obesity related traits and their response to high fat diet
data have shown linkage to the INSIG2 gene region and
with obesity related traits such as fat depots (reproductive,
renal, mesenteric, and inguinal) and serum cholesterol
levels [7].
A series of follow-up studies sought to validate the associ-
ation of INSIG2 rs7566605 with markers of obesity in
humans, with ten publications reporting inconsistent
findings [8-18]. Considering the larger studies, Loos et al.
[14] used the British European Prospective Investigation
of Cancer (EPIC) Norfolk study, an older population
(mean age 58 when DNA sample collected), and did not
find a significant association with BMI. Similarly, Dina et
al. [9] French Données Epidémiologiques sur le Syn-
drome d'Insulino-Résistance (DESIR) also studied older
insulin resistant subjects, and did not find an association
with BMI. In addition, the results from the Nurses Health
Study (NHS), that consists of women age 47, did not rep-
licate the original study by Herbert et al. [4]. The analysis
of German participants from the SHIP study by Rosskopf
et al. [16] did not report a positive association with BMI
when the samples were stratified by genotype and gender;
however, the subgroup of obese samples (BMI > 30) have
a higher frequency of the C allele than individuals that are
over-weight (BMI: 25–30). Interestingly, a recent study
examined the effect of genotype on weight loss (one year
intervention) and found that children with the CC geno-
type lost less weight than children with the GC/GG geno-
type [15]. Many of the non-replications of the reported
associated polymorphism and obesity may result from a
lack of power given the low incidence of obesity in many
of the populations examined.
Most of the previous studies on INSIG2 rs766605 have
been performed on patient cohorts or relatives of
probands recruited because of end stage disease pheno-BMC Medical Genetics 2008, 9:117 http://www.biomedcentral.com/1471-2350/9/117
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types such as hypertension, heart disease, cancer, type 2
diabetes mellitus and have used the relatively non-sensi-
tive and non-specific phenotype of BMI as a measure for
obesity [8-18]. We sought to use a more specific and sen-
sitive measure of adiposity in younger adults (average age
24 yrs), namely volumetric MRI measures of subcutane-
ous fat of the upper arm [19-22], to test for associations of
INSIG2 genotype and subcutaneous fat. We also opted to
stratify for gender, and limit to Caucasians, given variabil-
ity seen in previous associations of this SNP. Finally, we
examined if INSIG2 genotype affected change in subcuta-
neous fat with resistance training.
Methods
Subjects
The FAMuSS cohort is described elsewhere [21]. Briefly,
the population was derived from a multicenter, NIH
funded study designed to identify genetic factors that dic-
tate baseline bone, muscle and fat volume and the varia-
bility in response to exercise training. 752 healthy
Caucasian volunteers (18–40 yrs, FMS cohort; 451
women; 301 men; see Table 1) were enrolled in this study
by one of the 8 centers (University of Massachusetts
Amherst, University of Connecticut, Dublin University
(Ireland), Florida Atlantic University, Hartford Hospital,
University of Central Florida, West Virginia University,
Central Michigan University). The study was approved by
the Children's National Medical Center Institutional
Review Board (protocol #2449), and was in compliance
with the Helsinki Declaration. Participants were asked to
maintain their typical food intake, physical activity and
drug use (e.g. oral contraceptives) during the 12 wk
period.
Exercise Training Program
Resistant training (RT) was performed with the non-dom-
inant arm (trained arm). The protocol was described else-
where [21]. Briefly it consisted of two 45 – 60 minute
sessions per week for 12 weeks. Each session was super-
vised by an exercise physiologist professional or a trained
student. Before each session, participants warmed-up with
2 sets of 12 repetitions of the biceps preacher curl and the
seated overhead triceps extension. Each session included
dumbbell biceps curls, dumbbell biceps preacher curls,
and incline dumbbell biceps curls, overhead dumbbell tri-
ceps extension, and dumbbell triceps kickbacks. The
amount of weight was aggressively increased during the
12 wks.
MRI measurement
In the FAMuSS study, we were only able to obtain useable
MRI images from 517 of the individuals enrolled due to
the quality of some of the scans (see Table 1). Entry MRI
was done 24 to 48 h before the isometric or 1RM test.
Scans post-training MRI was performed 48 – 96 h after the
last training session. Fifteen 16 mm contiguous axial slices
from each arm were taken from each arm independently.
The top of the bead in a sagittal scout view was used to
locate the 8th slice going from the top of the arm toward
the elbow. Scans for both arms were taken by Fast Spoiled
Gradient Recalled (FSPPGR) and Fast Spin Echo (FSE)
with TE 1.8/TR 200 msec. All 8 centers submitted the MRI
data to the Research Center for Genetic Medicine at Chil-
Table 1: Subject Characteristics for the FAMuSS study
Characteristic Women Men
N Mean ± SD N Mean ± SD
Age (years) 320 22.87 ± 5.34 197 23.89 ± 5.71
Baseline weight (kg) 320 64.71 ± 12.44 197 78.77 ± 14.54
Baseline height (cm) 320 164.23 ± 6.73 197 178.46 ± 6.64
Baseline BMI 320 23.68 ± 4.28 197 24.68 ± 4.06
Baseline subcutaneous fat (trained arm) 320 257641 ± 116264 197 172577 ± 90778
Baseline subcutaneous fat (untrained arm) 319* 259102 ± 118598 197 176227 ± 97396
% change in subcutaneous fat (trained arm) 320 6.44 ± 67.05 197 3.56 ± 17.70
% change in subcutaneous fat (untrained arm) 319* 1.80 ± 10.42 197 1.02 ± 17.50
* One female had an unreadable MRI image of the untrained arm.BMC Medical Genetics 2008, 9:117 http://www.biomedcentral.com/1471-2350/9/117
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dren's National Medical Center (CNMC) in Washington,
D.C, via e-mail or DAT disc, and all scans were integrated
into the study SQL database.
For both cross-sectional and volumetric analysis of the
MRI images, we used Rapidia (INFINITT Inc, Seoul
Korea), a PC based software that allows the semi-auto-
matic quantification of muscle, bone and subcutaneous
fat [21,23]. Volume measures were taken using an ana-
tomical landmark (metaphyseal-diaphyseal junction of
the humerus) as our starting point and assayed the six 1
cM slices proximal to it. Measurement values were auto-
matically written and saved in a SQL database together
with anthropomorphic and genotyping data.
Genotyping
Blood samples were obtained from all individuals in
EDTA anticoagulant, sent to the coordinating site in
Washington, DC, without subject identification. The DNA
was isolated using Puregene kits (Gentra Systems, MN).
Genotyping was done using a TaqMan allele discrimina-
tion assay that employs the 5' nuclease activity of Taq
polymerase to detect a fluorescent reporter signal
(Applied Biosystems, assayID: C_29404113_20). Both
alleles were detected simultaneously using allele-specific
oligonucleotides labeled with different fluorophores, and
genotypes determined by the ratio of the two fluoro-
phores used. The PCR for the each SNP contained 20 ng
of DNA, 900 nM primers, 200 nM probes, and TaqMan
Universal PCR Master Mix, No AmpErase UNG Applied
Biosystems, Foster City, CA) in a final volume of 15 μL.
PCR was performed on an MJ Research Tetrad thermal
cycler (Waltham, MA). The PCR profile was 10 minutes at
95°C (denaturation), 44 cycles of 15 seconds at 92°C,
and 1 minute at an annealing temperature of 60°C. Reac-
tions were set up using a MWG robot, and fluorescence
ratios and allele calling done using an ABI 7900. To test
for reproducibility of our genotyping assay, 96 DNA sam-
ples were tested three times independently, and genotypes
compared. There was 100% concordance of genotypes in
all three replicates, with no dropouts, no calls, or ambig-
uous calls.
Statistical analysis
All analyses were stratified by gender as this is a well
known factor in genotype-phenotype correlations in
anthropomorphic measures, such as adiposity. Hardy-
Weinberg equilibrium was tested using a Chi-square anal-
ysis with one degree of freedom. Statistical tests of nor-
mality (Shapiro-Francia normality test) showed minor
deviations from normality, but visual inspection of phe-
notype histograms showed normal distributions. This and
the relatively high n's for our sample led us to use para-
metric tests. Associations between the SNP and each phe-
notype were testing using ANCOVA. Bivarate correlations
between phenotype and body weight and age showed
strong relationships; therefore each model included base-
line body weight and age as covariates. The % variability
attributable to genotype was determined by comparing
the full model (containing genotype and covariates) with
the constrained model (containing covariates only). Like-
lihood-ratio tests were done to determine if the variability
attributable to genotype was statistically significant. Anal-
yses used a nominal p-value of 0.05 as significant. To
address to some extent the problem of multiple testing,
we compared our unadjusted p-values to a significance
level of 0.007 (Bonferroni-adjusted for 7 phenotypes
tested). All analyses used Stata V10 (StataCorp, College
Station, TX).
Results
In our population of individuals that are of European
descent (Whites), the G allele frequency was 0.69 and C
allele was 0.31 (GG: n = 350, GC: n = 331, CC: n = 71).
This matches well with the allele frequencies from the
HAPMAP data set that reports an allele frequency for the
G allele of 0.725 and a frequency of 0.275 for the C allele
in the thirty U.S. trios provided samples, which were col-
lected in 1980 from U.S. residents with northern and
western European ancestry by the Centre d'Etude du Pol-
ymorphisme Humain. The rs7566605 variant was in
Hardy Weinberg Equilibrium in our population (p = 0.3).
For subcutaneous fat in the upper trained arm (Table 2),
women had baseline volumes of 257641 ± 116264 mm3
and gained an average of 5900 ± 31141 mm3 (2.2%) of
subcutaneous fat after the 12 weeks exercise intervention.
Similar values were obtained for both trained and
untrained arms, indicating a systemic effect of exercise on
subcutaneous adiposity. The untrained arm showed a
mean baseline volume of 2601186 ± 120065 mm3 with a
gain of 3668 ± 29388 mm3 (1.4%) that was not signifi-
cantly different from the trained arm. As expected, men
showed less baseline subcutaneous fat than women
(172577 ± 90778 mm3). In addition, men gained 2.5%
subcutaneous fat volume (4368 ± 24211 mm3) with sin-
gle arm resistance training after the 12 wk intervention.
The untrained arm showed a mean baseline volume of
176227 ± 97396 mm3 with a gain of 312 ± 29076 mm3
(0.2%) that was not significantly different from the
trained arm.
The INSIG2 SNP was associated with baseline subcutane-
ous fat volume (Table 3) (n = 320) in women in both
arms (trained arm: GG: n = 139; 243473 ± 5713 mm3 vs.
GC/CC: n = 181; 268521 ± 5003 mm3 [p = 0.001] and
untrained arm: GG: n = 138; 246095 ± 5682 mm3 vs. GC/
CC: n = 180; 270940 ± 4978 mm3 [p = 0.001]). Women
that were homozygous for the G allele had 9.3% less sub-
cutaneous fat than women in the trained and untrainedBMC Medical Genetics 2008, 9:117 http://www.biomedcentral.com/1471-2350/9/117
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arm with a copy of the C allele (Figure 1). This SNP
accounted for 1.1% of genotypic variance for subcutane-
ous fat in women.
Men with two copies of the G allele gained less percent
subcutaneous fat in the exercised arm than men with a
copy of the C allele (GG: n = 103; 1.02% ± 1.74% vs. GC/
CC: n = 93; 6.39% ± 1.82%; p = 0.035) (Table 3). Men
with a copy of the C allele gained 5.4% more subcutane-
ous fat than those men with two copies of the G allele.
There was no significant change in subcutaneous fat in the
untrained arm (GG: n = 103; 0.9% ± 1.7% vs. GC/CC: n =
93; 1.2% ± 1.8%; p=NS) (data not shown). Interestingly,
men with a copy of the C allele and a BMI < 30, gained
6.5% more subcutaneous fat (GG: n = 97; 0.79 ± 1.84 vs.
GC/CC: n = 81; 7.31 ± 2.02; p = 0.019). BMI was assessed
as a continuous phenotype with rs7566605 using
ANCOVA models (age as only covariate) in gender spe-
cific cohorts. We did not find a statistically significant
association between BMI and rs7566605 (p= 0.35 for
Table 2: Baseline and percent (%) fat and strength change in FAMUSS cohort with resistance training
Phenotype Arm Females (N = 320)
mean ± SD
Males (N = 197)
mean ± SD
Baseline subcutaneous fat volume (mm3) Trained 257641 ± 116264 172577 ± 90778
Untrained 260186 ± 120065* 176227 ± 97396
Subcutaneous fat volume gained with training (mm3) Trained 5900 ± 31141 4368 ± 24211
Untrained 3668 ± 29388* 312 ± 29076
* N = 319 due to one missing MRI phenotype in females
Significant association of INSIG2 rs7566605 genotype with baseline subcutaneous fat volume in white men and women Figure 1
Significant association of INSIG2 rs7566605 genotype with baseline subcutaneous fat volume in white men and 
women. In women, a copy of the C allele was associated with more subcutaneous fat. No significant differences were seen for 
subcutaneous fat volume in men. This model included baseline body weight and age as covariates.BMC Medical Genetics 2008, 9:117 http://www.biomedcentral.com/1471-2350/9/117
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females and p= 0.32 for males) in our study. Men with a
BMI ≥ 30 did not show significant gains in fat with a copy
of the C allele; however, the numbers were very small (n
= 18). There was also no significant changes in subcutane-
ous fat in the untrained arm for BMI stratified men (BMI
< 30: GG: 0.8% ± 1.8% vs. GC/CC: 1.1% ± 2.0% and BMI
≥ 30: GG: 1.2% ± 4.0 vs. GC/CC: 2.1% ± 2.8). Women did
not show an association with percent changes in subcuta-
neous fat with resistance training.
Other phenotypes tested for association with the INSIG2
SNP and the p-values are located in additional table 1.
Adjustment for multiple testing (7 phenotypes in male
and female cohorts) showed only the baseline subcutane-
ous fat in females to remain statistically significant.
Discussion
The associations of INSIG2 polymorphisms with approx-
imate measures of adiposity (BMI) have varied from
cohort to cohort (see additional table 2). Although BMI is
widely used as a surrogate measure of adiposity, it is a
measure of excess weight, rather than excess body fat, rel-
ative to height [2,3,20]. A study of BMI in more than 400
college athletes and non-athletes [24] reported that in
most cases the student's BMI did not accurately reflect his
or her percentage of body fat. We used a highly specific
and sensitive measure of adiposity, namely volumetric
semi-automated MRI volumes of upper arm, before and
after a unilateral 12 wk resistance training intervention.
This allowed us to assess the association of rs7566605
with baseline values of fat in the upper arm and also the
effect of the polymorphism with regards to loss or gain of
fat volumes following an intervention. It is important to
note that most previous studies of INSIG2 have focused
on older populations, with other morbidities, whereas we
focused on a young adult healthy volunteer population.
Therefore, our population was not exposed to as many
environmental influences as the older populations previ-
ously studied making our genetic association data less
affected by cofounding variables. Subjects were instructed
to maintain activity levels, food intake, and drug use at
similar levels before and during the intervention. A post-
hoc analysis using oral contraceptive/hormone as a cov-
ariate in females showed no significant effect. Calorie
intake and activity levels outside the strength intervention
were not specifically quantified, and this is a potential
limitation to this study.
We found the rs7566605 C allele to be associated with
increased baseline levels of subcutaneous fat in women
but not men (Figure 1). Our findings with baseline subcu-
taneous fat in young adult women are in general agree-
ment with studies that have found the C allele to be
associated with increased adiposity by other measures
(BMI). Lyon et al. genotyped rs7566605 in across multi-
ple ethnicities (total N = 16,969) and observed a signifi-
cant (p < 0.05) association with BMI in 5 cohorts out 8.
The authors suggested that the effect of SNP rs7566605 on
BMI may be heterogeneous across population samples.
However, in the same paper, a deCode cohort (N = 5,187)
showed a strong negative association between BMI and
rs7566605. Our findings are in general agreement with
Lyons et al. where the C allele in young adult females is
associated with increased adiposity as measured by subcu-
taneous fat volumes of the arm. In our young adult
cohort, we did not show a significant association between
BMI and rs7566605 for either sex (p = 0.35 for females
and p = 0.32 for males). Subcutaneous fat volumes are
thought to be a better measure of adiposity in young pop-
ulations, while BMI becomes a better phenotype in older
Table 3: Associations with INSIG2 rs7566605 phenotypes with baseline and percent (%) fat and strength change in FAMUSS cohort 
with resistance training.
Phenotype Gender P-value N; mean ± SEM 95% CI % variability attributable to 
genotype; LRT p-value
Baseline subcutaneous fat 
volume (mm3)
Female 0.0011 GG (N = 139; 243473 ± 5713)
GC/CC 
(N = 181; 268521 ± 5003)
GG (232233 – 254714)
GC/CC (258677 – 278365)
1.1%; 0.0010
Baseline subcutaneous fat 
volume (mm3)
Male 0.3557 GG (N = 103; 176503 ± 6100)
GC/CC 
(N = 94; 168275 ± 6389)
GG (164472 – 188534)
GC/CC (155675 – 180876)
0.2%; 0.3501
% change in subcutaneous fat 
volume
Female 0.2683 GG (N = 139; 11.20 ± 5.71)
GC/CC 
(N = 181; 2.78 ± 4.99)
GG (-0.02 – 22.43)
GC/CC (-7.05 – 12.61)
0.4%; 0.2649
% change in subcutaneous fat 
volume
Male 0.0353 GG (N = 103; 1.00 ± 1.74)
GC/CC (N = 94; 6.39 ± 1.82)
GG (-2.43 – 4.43)
GC/CC (2.78 – 10.01)
2.3%; 0.0332
All genetic models were dominant.BMC Medical Genetics 2008, 9:117 http://www.biomedcentral.com/1471-2350/9/117
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adults (see text below). Previous studies of associations of
rs7566605 used BMI, studied older cohorts, and generally
did not stratify by gender.
The recent articles have suggested there appear to be sig-
nificant gender differences in the storage and utilization
of fats [25]. Compared to males females have more subcu-
taneous adipose tissue and intramuscular triacylglycer-
ides. Furthermore, there is higher lipoprotein lipase
activity in adipocytes in males and this is correlated with
estrogen concentrations [25]. During endurance exercise
there is greater fat oxidation for females as compared to
males, and this may direct to glycogen and protein sparing
[25]. This may be related to greater insulin sensitivity in
females mediating an increase in free fatty acid synthase
and may also change with INSIG2 genotypes.
Particularly interesting is our finding of the associations of
rs7566605 C allele with loss and gain of subcutaneous fat
and muscle strength after a unilateral resistance training
of the arm; however these associations were not signifi-
cant if adjusted for multiple testing. Men generally gained
subcutaneous fat volume in both trained and untrained
arms (2–3% gain), but men with one or more copies of
the C allele showed 6–7% gains (Table 3). These data sug-
gest that exercise training may indeed lead to poorer
health outcomes in INSIG2 C carriers, in that even limited
localized exercise may trigger an increase in adiposity.
This finding is similar to a study of PPARα L162V poly-
morphism in this same population, where male carriers of
the rare allele also gained considerably greater adiposity
following unilateral resistance training of one arm [22].
For the INSIG2 polymorphism, the increased subcutane-
ous fat gain in men was exacerbated by an unexpected
decrease in muscle strength by isometric measures. Our
findings agree with a previous study that examined
rs7566605 in 293 obese children (mean age 10.8 years,
45% male, mean BMI 28.1 kg/m2) who participated in a
1-year exercise intervention [15]. Children with the CC
genotype lost less weight after the intervention than chil-
dren with a copy of the G allele (p = 0.007). This variant
plays a role in weight regulation that needs to be explored
further.
In our study, we did not analyze visceral adipose tissue
(VAT) but measured the subcutaneous fat in the upper
arm. Multiple studies have pointed out that VAT is more
closely associated with metabolic syndrome markers [26],
and that VAT secretes adipocytokines and other vasoactive
substances that directly influences the risk of developing
metabolic traits [27]. However, many of these associa-
tions have been done on older subjects, and visceral fat
generally increases with age, while subcutaneous fat may
decrease (particularly in aged subjects). There are also
numerous studies that show that both subcutaneous and
VAT fat can be associated with diabetes [27] and insulin
resistance [28,29]. We feel that our study may provide a
particularly sensitive window on adiposity, as our volu-
metric MRI done at a relatively young age should not be
subject to many of the uncontrolled confounding factors
active in previous studies.
Conclusion
The findings reported here show that a part of inter-indi-
vidual response to resistance training can be explained by
INSIG2 genotype. We need further studies to pinpoint the
effect that INSIG2 genotype has on the response of fat to
exercise and our exercise study did not control for diet.
However, this may be one of the first studies to examine
the effect of a genotype on the response of fat to exercise
and with this data we may begin to unravel genetics
behind the differences in fat response to exercise.
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